174 related articles for article (PubMed ID: 24021170)
1. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
Pianalto KM; Hartman JH; Boysen G; Miller GP
Toxicol Lett; 2013 Nov; 223(2):221-7. PubMed ID: 24021170
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
3. Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol.
Powley MW; Li Y; Upton PB; Walker VE; Swenberg JA
Carcinogenesis; 2005 Sep; 26(9):1573-80. PubMed ID: 15888494
[TBL] [Abstract][Full Text] [Related]
4. A novel DNA adduct, originating from 1,2-epoxy-3,4-butanediol, is the major DNA adduct after exposure to [2,3-(14)C]-1,3-butadiene,[4-(14)C]-1,2-epoxy-3-butane.
Boogaard PJ; van Sittert NJ; Watson WP; de Kloe KP
Chem Biol Interact; 2001 Jun; 135-136():687-93. PubMed ID: 11397423
[TBL] [Abstract][Full Text] [Related]
5. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
Bond JA; Medinsky MA
Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
[TBL] [Abstract][Full Text] [Related]
6. The importance of 3,4-epoxy-1,2-butanediol and hydroxymethylvinyl ketone in 3-butene-1,2-diol associated mutagenicity.
Powley MW; Walker VE; Li Y; Upton PB; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):182-90. PubMed ID: 17349618
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of 1,3-butadiene to toxicologically relevant metabolites in single-exposed mice and rats.
Filser JG; Hutzler C; Meischner V; Veereshwarayya V; Csanády GA
Chem Biol Interact; 2007 Mar; 166(1-3):93-103. PubMed ID: 16616907
[TBL] [Abstract][Full Text] [Related]
8. A review of the genetic and related effects of 1,3-butadiene in rodents and humans.
Jackson MA; Stack HF; Rice JM; Waters MD
Mutat Res; 2000 Oct; 463(3):181-213. PubMed ID: 11018742
[TBL] [Abstract][Full Text] [Related]
9. First-pass metabolism of 1,3-butadiene in once-through perfused livers of rats and mice.
Filser JG; Faller TH; Bhowmik S; Schuster A; Kessler W; Pütz C; Csanády GA
Chem Biol Interact; 2001 Jun; 135-136():249-65. PubMed ID: 11397395
[TBL] [Abstract][Full Text] [Related]
10. Quantitative investigation on the metabolism of 1,3-butadiene and of its oxidized metabolites in once-through perfused livers of mice and rats.
Filser JG; Bhowmik S; Faller TH; Hutzler C; Kessler W; Midpanon S; Pütz C; Schuster A; Semder B; Veereshwarayya V; Csanády GA
Toxicol Sci; 2010 Mar; 114(1):25-37. PubMed ID: 20007191
[TBL] [Abstract][Full Text] [Related]
11. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes.
Seaton MJ; Follansbee MH; Bond JA
Carcinogenesis; 1995 Oct; 16(10):2287-93. PubMed ID: 7586124
[TBL] [Abstract][Full Text] [Related]
13. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA
Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395
[TBL] [Abstract][Full Text] [Related]
14. Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene.
Georgieva NI; Boysen G; Bordeerat N; Walker VE; Swenberg JA
Toxicol Sci; 2010 Jun; 115(2):322-9. PubMed ID: 20176624
[TBL] [Abstract][Full Text] [Related]
15. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
Booth ED; Kilgour JD; Robinson SA; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
Csanády GA; Guengerich FP; Bond JA
Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
[TBL] [Abstract][Full Text] [Related]
17. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
18. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides.
Boysen G; Georgieva NI; Upton PB; Walker VE; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):84-92. PubMed ID: 17084829
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory potency of 4-carbon alkanes and alkenes toward CYP2E1 activity.
Hartman JH; Miller GP; Boysen G
Toxicology; 2014 Apr; 318():51-8. PubMed ID: 24561005
[TBL] [Abstract][Full Text] [Related]
20. DNA adducts in rats and mice following exposure to [4-14C]-1,2-epoxy-3-butene and to [2,3-14C]-1,3-butadiene.
Boogaard PJ; de Kloe KP; Booth ED; Watson WP
Chem Biol Interact; 2004 Jun; 148(1-2):69-92. PubMed ID: 15223358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
